HLIO

Helios Technologies, Inc.

77
Fundamentals82/ 100
Valuation83/ 100
Upside potential72/ 100
Risk potential16/ 100

HLIO has the edge over RKLB overall, supported by stronger valuation and lower modeled downside.

RKLB

Rocket Lab USA, Inc.

56
Fundamentals66/ 100
Valuation50/ 100
Upside potential66/ 100
Risk potential46/ 100

RKLB's outlook is improving, though it still trails on the overall score.

HLIO Fundamentals

MetricStatus
Stable
Strong
Strong
Healthy

HLIO's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.

RKLB Fundamentals

MetricStatus
Strong
Under pressure
Weak
Unavailable

RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

HLIO PE Valuation

CHEAPFAIREXPENSIVE46x92x138x184x
CHEAPFAIREXPENSIVE46x92x138x184x
LevelPEPriceVs current
Forward14x$47.69—
Current20x$47.69—
Cheap21x$50.21+5.3%
Fair37x$88.21+85%
Expensive53x$126+163%

Historical ranges are pointers, not guarantees.

HLIO's PE is in its cheap range at 20x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.

RKLB PE Valuation

RKLB has no meaningful PE right now: it lost money over the past year.

HLIO Forward outlook

MetricOutlook
Strongly improving
Growth
Growth
Improving
Limited
Moderate

Analysts expect earnings and revenue growth for HLIO, with profitability improving.

RKLB Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
Low

Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

HLIO Risk to reward

ScenarioChangePrice
Upside+41%$67.15
Downside-16%$40.28

Calculated from the latest close: $47.69 on Nov 12.

HLIO has a better modeled risk to reward balance than RKLB, with more potential upside relative to its potential downside.

RKLB Risk to reward

ScenarioChangePrice
Upside+88%$120.71
Downside-46%$34.64

Calculated from the latest close: $64.07 on Nov 12.

RKLB trails HLIO on modeled risk to reward, with less potential upside relative to its potential downside.

HLIO Earnings Per Share

Q4 2023: $1.14Q1 2024: $1.00Q2 2024: $0.90Q3 2024: $1.13Q4 2024: $1.17Q1 2025: $1.11Q2 2025: $1.04Q3 2025: $1.01Q1 2026: $1.45Q2 2026: $1.82Q3 2026: $2.14Q4 2026: $2.36Forward: $3.30
Q4 2023: $1.14Q1 2024: $1.00Q2 2024: $0.90Q3 2024: $1.13Q4 2024: $1.17Q1 2025: $1.11Q2 2025: $1.04Q3 2025: $1.01Q1 2026: $1.45Q2 2026: $1.82Q3 2026: $2.14Q4 2026: $2.36Forward: $3.30
QuarterTTM EPSYoY
Forward$3.30+40%
Q3 2026$2.36+134%
Q2 2026$2.14+106%
Q1 2026$1.82+64%
Q4 2025$1.45+24%
Q3 2025$1.01-11%
Q2 2025$1.04+16%
Q1 2025$1.11+11%
Q4 2024$1.17+2.6%

HLIO has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.

RKLB Earnings Per Share

Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
QuarterTTM EPSYoY
Q3 2026-$0.36+$0.03
Q2 2026-$0.27+$0.19
Q1 2026-$0.32+$0.09
Q4 2025-$0.37+$0.01
Q3 2025-$0.39-$0.02
Q2 2025-$0.46-$0.11
Q1 2025-$0.41-$0.04
Q4 2024-$0.38$0.00

RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.

HLIO Quarterly Revenue

Q4 2023: $193MQ1 2024: $212MQ2 2024: $220MQ3 2024: $195MQ4 2024: $180MQ1 2025: $196MQ2 2025: $213MQ3 2025: $220MQ1 2026: $211MQ2 2026: $228MQ3 2026: $232MQ4 2026: $230M
Q4 2023: $193MQ1 2024: $212MQ2 2024: $220MQ3 2024: $195MQ4 2024: $180MQ1 2025: $196MQ2 2025: $213MQ3 2025: $220MQ1 2026: $211MQ2 2026: $228MQ3 2026: $232MQ4 2026: $230M
QuarterRevenueYoY
Q3 2026$229.7M+4.3%
Q2 2026$231.9M+9.1%
Q1 2026$228.4M+17%
Q4 2025$210.8M+17%
Q3 2025$220.3M+13%
Q2 2025$212.5M-3.4%
Q1 2025$195.5M-7.8%
Q4 2024$179.5M-7.2%

HLIO's revenue has grown year over year for five quarters in a row: $230M last quarter, up 4.3% from the same quarter a year ago.

RKLB Quarterly Revenue

Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
QuarterRevenueYoY
Q3 2026$267.8M+73%
Q2 2026$234.1M+62%
Q1 2026$200.3M+63%
Q4 2025$179.7M+36%
Q3 2025$155.1M+48%
Q2 2025$144.5M+36%
Q1 2025$122.6M+32%
Q4 2024$132.4M+121%

RKLB has the edge over HLIO on sales, with more consistent year-over-year improvement.

HLIO Free Cash Flow

Q4 2023: $25MQ1 2024: $12MQ2 2024: $26MQ3 2024: $29MQ4 2024: $28MQ1 2025: $13MQ2 2025: $32MQ3 2025: $19MQ1 2026: $41MQ2 2026: $17MQ3 2026: $31MQ4 2026: $32M
Q4 2023: $25MQ1 2024: $12MQ2 2024: $26MQ3 2024: $29MQ4 2024: $28MQ1 2025: $13MQ2 2025: $32MQ3 2025: $19MQ1 2026: $41MQ2 2026: $17MQ3 2026: $31MQ4 2026: $32M
QuarterFree cash flowYoY
Q3 2026$32.4M+74%
Q2 2026$30.6M-3.2%
Q1 2026$17.2M+33%
Q4 2025$40.5M+43%
Q3 2025$18.6M-35%
Q2 2025$31.6M+22%
Q1 2025$12.9M+4.9%
Q4 2024$28.3M+14%

HLIO has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.

RKLB Free Cash Flow

Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
QuarterFree cash flowYoY
Q3 2026-$23.9M+$45.5M
Q2 2026-$110.1M-$54.8M
Q1 2026-$77.4M+$5.5M
Q4 2025-$114.2M-$90.2M
Q3 2025-$69.4M-$27.5M
Q2 2025-$55.3M-$26.9M
Q1 2025-$82.9M-$61.1M
Q4 2024-$23.9M+$28.7M

RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.

HLIO Total Shares

Q4 2023: 33MQ1 2024: 33MQ2 2024: 33MQ3 2024: 33MQ4 2024: 33MQ1 2025: 33MQ2 2025: 33MQ3 2025: 33MQ1 2026: 33MQ2 2026: 33MQ3 2026: 33MQ4 2026: 33M
Q4 2023: 33MQ1 2024: 33MQ2 2024: 33MQ3 2024: 33MQ4 2024: 33MQ1 2025: 33MQ2 2025: 33MQ3 2025: 33MQ1 2026: 33MQ2 2026: 33MQ3 2026: 33MQ4 2026: 33M
PeriodChange %Net change
Quarterly-0.6%-200K shares
1 year-0.9%-300K shares
3 years-0.3%-100K shares
5 years+1.9%+615K shares
Available history+3.1%+985K shares

HLIO has the edge over RKLB on shareholder dilution, with a more favorable share count trend.

RKLB Total Shares

Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
PeriodChange %Net change
Quarterly+3.6%+22.6M shares
1 year+23%+124M shares
3 years+35%+168M shares
5 years+46%+204M shares

RKLB has 652M diluted shares, up 23% from a year ago.

HLIO Net Leverage

Q4 2023: 2.0xQ1 2024: 2.0xQ2 2024: 1.9xQ3 2024: 1.8xQ4 2024: 1.8xQ1 2025: 1.8xQ2 2025: 1.7xQ3 2025: 1.9xQ1 2026: 1.5xQ2 2026: 1.3xQ3 2026: 1.1xQ4 2026: 1.4x
Q4 2023: 2.0xQ1 2024: 2.0xQ2 2024: 1.9xQ3 2024: 1.8xQ4 2024: 1.8xQ1 2025: 1.8xQ2 2025: 1.7xQ3 2025: 1.9xQ1 2026: 1.5xQ2 2026: 1.3xQ3 2026: 1.1xQ4 2026: 1.4x
QuarterNet LeverageStatus
Q3 20261.4xHealthy
Q2 20261.1xHealthy
Q1 20261.3xHealthy
Q4 20251.5xHealthy
Q3 20251.9xHealthy
Q2 20251.7xHealthy
Q1 20251.8xHealthy
Q4 20241.8xHealthy

HLIO's net debt is about 1.4 years of its operating earnings (EBITDA), down from 1.9 years a year ago.

RKLB Net Leverage

RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

HLIO Weekly Momentum

MetricValueStatus
RSI24.8Oversold
Stochastic3.3Oversold

HLIO's weekly RSI is 25 (oversold) and its Stochastic is 3 (oversold).

RKLB Weekly Momentum

MetricValueStatus
RSI46.8Neutral
Stochastic27.6Neutral

RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).

HLIO PE vs Industrials Sector

MetricHLIOSector medianRelative
PE20x24x16% below
PE %125846 pts below

HLIO is trading at 20x earnings, a 16% discount to the Industrials sector's median of 24x.

RKLB PE vs Industrials Sector

RKLB has no meaningful PE right now: it lost money over the past year.

HLIO Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$63.124% below
20 week MA$71.633% below
50 week MA$70.232% below
100 week MA$56.015% below
200 week MA$53.911% below

HLIO is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.

RKLB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$61.44.3% above
20 week MA$68.15.9% below
50 week MA$77.617% below
100 week MA$56.513% above
200 week MA$31.4104% above

RKLB has the edge over HLIO on trend strength, trading above more of its moving averages.

HLIO Yearly ROI

YearStart priceEnd priceROI
2020$45.5$52.8+16%
2021$52.8$103.1+95%
2022$103.1$54.8-47%
2023$54.8$45.4-17%
2024$45.4$45.0-0.8%
2025$45.0$55.5+23%
2026 YTD$55.5$47.7-14%

HLIO has finished lower in three of the last six years. It's down 14% so far in 2026.

RKLB Yearly ROI

YearStart priceEnd priceROI
2020$9.82$10.3+4.9%
2021$10.3$12.0+17%
2022$12.0$3.77-69%
2023$3.77$5.53+47%
2024$5.53$27.2+392%
2025$27.2$70.7+160%
2026 YTD$70.7$64.1-9.3%

RKLB has the edge over HLIO on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key